Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections

Item
http://www.wikidata.org/entity/Q33938132
Canadian practice guidelines for surgical intra-abdominal infectionsCan we prevent antimicrobial resistance by using antimicrobials better?Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trialsRisk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis.Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.Rates of gastrointestinal tract colonization of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa in hospitals in Saudi ArabiaEmergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patientsEpidemiological interpretation of studies examining the effect of antibiotic usage on resistanceManagement of severe sepsis of abdominal origin.Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study.Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferioritImpact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.Impact of ertapenem on antimicrobial resistance in a sentinel group of Gram-negative bacilli: a 6 year antimicrobial resistance surveillance study.Piperacillin-tazobactam as alternative to carbapenems for ICU patients.Mortality rate in neonates infected with extended-spectrum beta lactamase-producing Klebsiella species and selective empirical use of meropenem.
P2860

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections

Item
http://www.wikidata.org/entity/Q33938132
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Acquisition of resistant bowel ...... for intraabdominal infections
@ast
Acquisition of resistant bowel ...... for intraabdominal infections
@en
type
label
Acquisition of resistant bowel ...... for intraabdominal infections
@ast
Acquisition of resistant bowel ...... for intraabdominal infections
@en
prefLabel
Acquisition of resistant bowel ...... for intraabdominal infections
@ast
Acquisition of resistant bowel ...... for intraabdominal infections
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Acquisition of resistant bowel ...... for intraabdominal infections
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.49.8.3217-3221.2005
P407
P433
P478
P50
P577
P698
P932